invasive meningococcal disease
Vaccines · 2018–2023
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| meningococcal (groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine Prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroups A, C, W-135 and Y in adolescents aged 14 to 19 years. | Nov 2023 | Recommended | none received |
| meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine Prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroups A, C, W-135, and Y in children aged 12 months, adolescents aged… | Nov 2020 | Recommended with restriction | none received |
| meningococcal serogroups A, C, W-135 and Y oligosaccharides conjugate CRM197 Prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroups A, C, W-135 and Y in adolescents aged approximately 15 years… | Jul 2018 | Recommended with restriction | 1 individuals Meningitis Centre Australia |
| meningococcal polysaccharide conjugate vaccine serogroups A, C, W-135 and Y Prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroups A, C, W-135, and Y in adolescents aged 14-16 years (Year 10)… | Mar 2018 | Recommended with restriction | none received |
| meningococcal polysaccharide conjugate vaccine serogroups A, C, W-135 and Y Prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroups A, C, W-135, and Y in infants at 12 months of age. | Mar 2018 | Recommended | 2 individuals |
Who spoke
Meningitis Centre Australia
Registered, not subsidised
Medicines on the ARTG for this condition with no PBAC record at all. Registration and subsidy are separate decisions: a medicine can be legally available in Australia and never have been put to the committee.
| Medicine | On the ARTG since | Registrations |
|---|---|---|
| meningococcal polysaccharide group a + meningococcal polysaccharide group c + meningococcal polysaccharide group w + meningococcal polysaccharide group yMenQuadfi meningococcal (Groups A,C,Y,W) polysaccharide tetanus toxoid | 2020 | 1 |
The ARTG export holds current registrations only, so the year is the earliest entry still on the register rather than a first-registration date. The condition here comes from the registered label, which is usually broader than the population a sponsor asks to have subsidised.
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 5 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.